Posted: September 23, 2011 at 9:07 pm

Overview and Profile Axiogenesis is an innovative and productive biotechnology company located in Cologne, Germany. Its primary focus is to develop novel assays that use differentiated embryonic stem cell (ES) and induced pluripotent stem cell (iPS) derived cell types that display normal physiological behavior. These cells are used in pharmacology and safety screening in the pharmaceutical, chemical, and cosmetics industries.

See the article here:

Related Post

Comments are closed.